France· FR:60378168
APROKAM 50 mg, poudre pour solution injectable
A medicinal product containing céfuroxime sodique, registered in France by THEA.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CÉFUROXIME SODIQUE
- Manufacturer
- THEA
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340095502851210 flacons en verre de 50 mg avec 10 aiguilles filtres de 5 microns stériles
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Céfuroxime sodique in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAprokam 50 mgLaboratoires Théa
- CzechiaAPROKAMLaboratoires Thea, Clermont-Ferrand
- United KingdomAprokam 50mg powder for solution for injection vialsThea Pharmaceuticals Ltd
- SpainCEFUROXIMA HELM 50 MG POLVO PARA SOLUCION INYECTABLEHelm Ag
- SwedenAprokam 50 mg Pulver till injektionsvätska, lösningLaboratoires THEA
- PolandAprokamLaboratoires Thea
- NetherlandsXimaract 50 mg, poeder voor oplossing voor injectieBausch + Lomb Ireland Limited
- NorwayAprokamLaboratoires Théa S.A.S
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Aprokam, Cefuroxim Aptapharma
- Belgium · Aprokam, Cefuroxim Fresenius Kabi
- Bulgaria · Аксетин, Аксеф
- Cyprus · Axetine, Cefurax
- Czechia · Aprokam, Axetine
- Germany · Aprokam, Cefurax
- Denmark · Aprokam, Cefuroxim B. Braun
- Estonia · Axetine, Cefuroxime Mip
- Spain · Cefuroxima Alter, Cefuroxima Cinfa
- Finland · Aprokam, Cefirion
- United Kingdom (Northern Ireland) · Aprokam, Cefuroxime
- Greece · Anaptivan, Cefur
- Croatia · Axetine, Beloxim
- Hungary · Cefuroxim Kabi, Cefuroxime Aptapharma
- Ireland · Aprok, Ceftal
- Iceland · Aprokam, Cefuroxim Fresenius Kabi
- Italy · Aprokam, Cefuroxima K24 Pharmaceuticals
- Lithuania · Axetine, Cefuroxime Mip
- Luxembourg · Aprokam, Cefuroxim Fresenius
- Latvia · Axetine, Cefuroxime Bcpp
- Malta · Axetine, Cefuroxime Axetil Ccav
- Netherlands · Aprokam, Cefuroxim Fresenius Kabi
- Norway · Aprokam, Cefuroxim B. Braun
- Poland · Aprokam, Biofuroksym
- Portugal · Antibioxime, Aprokam
- Romania · Aprokam, Axetine
- Sweden · Aprokam, Cefuroxim Mip
- Slovenia · Aprokam, Cefuroksim Aptapharma
- Slovakia · Aprokam, Axetine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3dc2a852-f004-468c-a0dd-779deeac1f7c GET /v1/drugs/3dc2a852-f004-468c-a0dd-779deeac1f7c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60378168",
"date_amm": "2012-09-26",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CÉFUROXIME SODIQUE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "intracamérulaire",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about céfuroxime sodique.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.